Gil-Prieto R, Pérez-Martín J, Díaz Aguiló A, Soudani S, Platero-Alonso L, López-Belmonte JL, de la Cuadra-Grande A, Casado MA, Alvarez Aldean J
Estimating the economically justifiable price of nirsevimab vs. Standard of Practice for the prevention of respiratory syncytial virus infections in neonates and infants in Spain: A cost-utility modeling study
BMJ Public Health. 2025;3(2):e002441. doi: 10.1136/bmjph-2024-002441
Harper DM, Navarro-Alonso JA, Bosh FX, Paavonen J, Stanley M, Sasieni P, Yébenes M, Martínez-Martínez N, Rodríguez A, García A, Martín-Gómez L, Vallejo-Aparicio L, Carrión H, Ruiz García Y
Impact of human papillomavirus vaccines in the reduction of infection, precursor lesions, and cervical cancer: A systematic literature review.
Hum Vaccin Immunother. 2025 (1):2497608. doi: 10.1080/21645515.2025.2497608
Gil-Prieto R, Pérez JJ, Díaz-Aguiló A, Soudani S, López-Belmonte JL, de la Cuadra-Grande A, Casado MA,Álvarez Aldean J
Estimación del precio de nirsevimab en España para la prevención de la infección por virus respiratorio sincitial en lactantes según umbrales de disponibilidad a pagar mediante un análisis coste-utilidad
XII Congreso de la Asociación Española de Vacunología (AEV). Málaga. 24-26 oct 2024
Forcada-Segarra JA, Cuesta-Esteve I, García-Pérez A, Sancho Martínez R, Rey Biel P, Carrera-Barnet G, de la Cuadra-Grande A, Casado MA, Drago G, Gómez-Barrera M, López-Belmonte JL
Nurses’ preferences regarding MenACWY conjugate vaccines attributes: a discrete choice experiment in Spain
Public Health 230 (2024) 163e171
Harper D, Navarro-Alonso JA, Bosch X, Gilca V, Paavonen J, Stanley M, Sasieni P, Yébenes M, Martínez N, Rodríguez Á, García A, Martín L, Vallejo L, Carrión H, Ruíz García Y
Clinical impact of human papillomavirus vaccines in the reduction of cervical cancer, precursor lesions and infections: a systematic literature review
35th International Papillomavirus Conference – IPVC 2023. Washington DC, USA. 17 abr 2023
Rodríguez González-Moro JM, Menéndez R, Campins M, Lwoff N, Oyagüez I, Echave M, Rejas J, Antoñanzas F
Cost-effectiveness of 13-valent conjugate pneumococcal vaccination program in COPD patients aged 50+ years in Spain
Clin Drug Investig. 2016;36:41-53
Menéndez R, Rodríguez-GonzálezMoro JM, Gros B, Echave M, Oyagüez I, Lwoff N, Egea-García M, Guijarro P
Cost-effectiveness of a 13-valent conjugate pneumococcal vaccination program in COPD patients aged ≥50 years in Spain: Preliminary results
16th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Dublin, Irlanda. 2-6 nov 2013
Garcia-Jurado L , Morano R, Torné A, Malvar A, Bayas JM, Pérez-Escolano I, Casado MA
Cost-efectiveness analysis of cervical cancer vaccination strategies in Spain
14th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Madrid, Spain 5-8 nov 2011
Torné A, Bayas JM, Malvar A, Morano R, Garcia-Jurado L, Pérez-Escolano I, Casado MA